RWD225 COST-EFFECTIVENESS OF DOCETAXEL VERSUS IMMUNE CHECKPOINT INHIBITORS AS TREATMENT FOR ADVANCED/METASTATIC NON-SMALL CELL LUNG CANCER: A TARGETED LITERATURE REVIEW
Abstract
Authors
Jorge F. Nino de Rivera Guzman Bruce Wang Philip Li